title: Distributions of five common point mutants in the human tracheal-bronchial epithelium.
abstract: The mutations C742T, G746T, G747T in the TP53 gene and G35T in the KRAS gene have been repeatedly found in sectors of human tumors by direct DNA sequencing. The mutation G508A in the HPRT1 gene has been repeatedly found among peripheral T lymphocytes by clonal expansion under selective conditions. To discover if these mutations also occur frequently in normal tissues from which tumors arise, we have developed and validated allele-specific mismatch amplification mutation assays (MAMA) for each mutation. Reconstruction experiments demonstrated linearity in the range of 9-3000 mutant alleles among 3 x 10(6) wild-type alleles. The cumulative distributions of all negative controls established robust detection limits (P<0.05) of 34-125 mutants per 10(6) copies assayed depending on the mutation. One hundred and seventy-seven micro-anatomical samples of approximately (0.5-6)x10(6) tracheal-bronchial epithelial cells from nine non-smokers were assayed representing en toto the equivalent of approximately 1.6 human bronchial trees to the fifth bifurcation. Statistically significant mutant copy numbers were found in 257 of 463 assays. Clusters of mutant copies ranged from 10 to 1000 in 239/257 positive samples. As all five point mutations were detected at mutant fractions of >10(-5) in two or more lungs, we infer that they are mutational hotspots generated in lung epithelial stem cells. As the cancer-associated mutations did not differ in cluster size distribution from the HPRT1 mutation, we infer that none of the mutations conferred a growth advantage to somatic heterozygous clusters or maintenance turnover units. Specific mutants appeared in very large copy numbers, 1000-35,000, in 18/257 positive assays. Various hypotheses to account for the observed cluster size distributions are offered.
authors.affiliation: Massachusetts Institute of Technology, 77 Massachusetts Ave., Bldg. 16-743 Cambridge, MA 02139, USA.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Sudo
authors.forename: Xiao-Cheng
authors.initials: XC
authors.lastname: Li-Sucholeiki
authors.forename: Luisa A
authors.initials: LA
authors.lastname: Marcelino
authors.forename: Amanda N
authors.initials: AN
authors.lastname: Gruhl
authors.forename: Helmut
authors.initials: H
authors.lastname: Zarbl
authors.forename: James C
authors.initials: JC
authors.lastname: Willey
authors.forename: William G
authors.initials: WG
authors.lastname: Thilly
mesh_terms: D000328:Adult; D000368:Aged; D001483:Base Sequence; D001980:Bronchi / Q000166:cytology*; D002460:Cell Line; D017931:DNA Primers; D005260:Female; D016158:Genes, p53; D011905:Genes, ras; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics; D008297:Male; D008875:Middle Aged; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D020545:Respiratory Mucosa / Q000502:physiology*; D013601:T-Lymphocytes / Q000502:physiology; D014132:Trachea / Q000166:cytology*; D018631:ras Proteins
chemical_list: D017931:DNA Primers; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D007041:Hypoxanthine Phosphoribosyltransferase; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins